Dominant-negative variant in SLC1A4 causes an autosomal dominant epilepsy syndrome.
Dominant-negative variant in SLC1A4 causes an autosomal dominant epilepsy syndrome.
复制标题
DOI:
10.1002/acn3.51786
复制
发表时间:
2023-06
影响因子:
5.3
通讯作者:
Stergachis, Andrew B.
中科院分区:
文献类型:
--
作者:
Pujol-Gimenez, Jonai;Mirzaa, Ghayda;Blue, Elizabeth E.;Albano, Giuseppe;Miller, Danny E.;Allworth, Aimee;Bennett, James T.;Byers, Peter H.;Chanprasert, Sirisak;Chen, Jingheng;Doherty, Daniel;Folta, Andrew B.;Gillentine, Madelyn A.;Glass, Ian;Hing, Anne;Horike-Pyne, Martha;Leppig, Kathleen A.;Parhin, Azma;Ranchalis, Jane;Raskind, Wendy H.;Rosenthal, Elisabeth A.;Schwarze, Ulrike;Sheppeard, Sam;Strohbehn, Samuel;Sybert, Virginia P.;Timms, Andrew;Wener, Mark;Bamshad, Michael J.;Hisama, Fuki M.;Jarvik, Gail P.;Dipple, Katrina M.;Hediger, Matthias A.;Stergachis, Andrew B.
SLC1A4 is a trimeric neutral amino acid transporter essential for shuttling L‐serine from astrocytes into neurons. Individuals with biallelic variants in SLC1A4 are known to have spastic tetraplegia, thin corpus callosum, and progressive microcephaly (SPATCCM) syndrome, but individuals with heterozygous variants are not thought to have disease. We identify an 8‐year‐old patient with global developmental delay, spasticity, epilepsy, and microcephaly who has a de novo heterozygous three amino acid duplication in SLC1A4 (L86_M88dup). We demonstrate that L86_M88dup causes a dominant‐negative N‐glycosylation defect of SLC1A4, which in turn reduces the plasma membrane localization of SLC1A4 and the transport rate of SLC1A4 for L‐serine.
登录
查看更多内容
影响因子:
6
作者:
Stehantsev P;Stetsenko A;Nemchinova M;Aduri NG;Marrink SJ;Gati C;Guskov A
通讯作者:
Guskov A
影响因子:
1.9
作者:
Sarigecili, Esra;Bulut, Fatma Derya;Anlas, Ozlem
通讯作者:
Anlas, Ozlem
影响因子:
5.4
作者:
Marin, M;Lavillette, D;Kabat, D
通讯作者:
Kabat, D
影响因子:
3.5
作者:
Heimer, G.;Marek-Yagel, D.;Ben Zeev, B.
通讯作者:
Ben Zeev, B.
影响因子:
1.9
作者:
Sedlackova, Lucie;Lassuthova, Petra;Seeman, Pavel
通讯作者:
Seeman, Pavel